...of Therapure along with rights to plasma products and technology in China. At that time, Therapure's...
...8, 2017 ). Therapure Biopharma's remaining IP includes its protein-drug conjugation and half-life extension technologies. Therapure Biopharma Inc....
...Mississauga, Ontario Business: Biomanufacturing Shannon Lehnbeuter IV-Globulin SN Inj (Brand), IVIG-SN (Informal), IV-Globulin SN inj (Informal) Evolve Biologics Inc. Therapure Biopharma Inc. Albumin...

...the private equity arm of CITIC, will acquire the contract development and manufacturing business of Therapure Biopharma Inc....
...to innovation. The company is developing antibodies and biologics in nephrology, oncology and autoimmune indications. Therapure's...
...close this year. Therapure Biopharma Inc. , Mississauga, Ontario 3SBio Inc. (HKSE:1530), Shenyang, China Business: Biomanufacturing Alicia Parker 3SBio Inc. Therapure Biopharma Inc....

...the private equity arm of CITIC, will acquire the contract development and manufacturing business of Therapure Biopharma Inc....
...to innovation. The company is developing antibodies and biologics in nephrology, oncology and autoimmune indications. Therapure's...
...of its holdings in the JV to 3SBio after four years. The JV will retain Therapure’s...

...Up to $86.3M IND Cancer Prevention Pharmaceuticals Inc. (NYSE) 12/23/15 Up to $30.1M Ph III Therapure Biopharma Inc....

...raised: TBD Shares: TBD Price: TBD Underwriters: GMP Securities; CIBC World Markets; National Bank Note: Therapure...

...Antitope and Therapure partnered to develop humanized therapeutic mAbs for several indications using Antitope's Composite Human...
...using Antitope's Composite Human Antibody technology. Terms were not disclosed. Antitope Ltd. , Babraham, U.K. Therapure Biopharma Inc....